CRDL
Cardiol Therapeutics
CRDL
CRDL
35 hedge funds and large institutions have $3.54M invested in Cardiol Therapeutics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
35
Holding in Top 10
–
Calls
$2K
Puts
–
Top Buyers
| 1 | +$844K | |
| 2 | +$51.9K | |
| 3 | +$38.5K | |
| 4 |
LNWTC
Laird Norton Wetherby Trust Company
Seattle,
Washington
|
+$29.9K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$29.5K |
Top Sellers
| 1 | -$557K | |
| 2 | -$97.5K | |
| 3 | -$74.8K | |
| 4 |
Goldman Sachs
New York
|
-$37.5K |
| 5 |
Jane Street
New York
|
-$20.6K |